We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Trega Biosciences (TRGA), formerly HPIP

No earlier versions found for this Subject.

Return to Trega Biosciences (TRGA), formerly HPIP
To All: Check our Houghten Pharmacutical (HPIP) H&Q rates as a Buy

H&Q has a $20 price target--stock at $5 1/8 now. Massive insider buying the past two months!!! The company has $31.4 million in cash, and is a leader in combinational chemistry--an exciting new branch of the biotech industry that focuses on a novel and highly efficient method of drug synthesis and lead molecule discovery. This stock could provide enormous returns over the next few years at todays price.
Do your research--H&Q research at Check out the massive insider buying at the sec site. Do your research--I will not have the time to answer individual questions on this company-sorry--but do your own research--it will be very profitable. Best wishes to all.